Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Transient Receptor Potential (TRP) Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.

NCT03211325 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03211325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03211325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Transient Receptor Potential (TRP) Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Completed
Start date
October 18, 2016
Completion date
June 27, 2019
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, raynaud's phenomenon (secondary), raynaud's phenomenon isolated primary